• BIOMUNEX is actively seeking partnerships and collaborations with pharma and biotech companies that are interested in either licensing its proprietary innovative technology to create unique BiXAb antibodies that target antigens of interest for industrial partners or licensing innovative molecules currently being developed by BIOMUNEX.